COVID-19multiple sclerosispwMS
…g BCD therapy have limited antibody boosting following repeated COVID-19 vaccination. However, the absence of severe outcomes in pwMS, d…
19articles mentioning diseases
68disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: PwMS ×
PwMS
This disease is selected. Its supporting articles are shown below.
Articles mentioning PwMS
19 articles · page 1 of 2multiple sclerosispwMScomplementary therapies
…valuating the effects of complementary therapies in people with multiple sclerosis (pwMS). We sought to identify the outcomes most relevant to pwM…
Multiple SclerosispwMSMS-Control
…Introduction Using an algorithm to identify people with Multiple Sclerosis (pwMS) in routine healthcare data we determined if there was an…
pwMScancermultiple sclerosiscancer-specificCare Register for Healthcare
…ontrols. Mean age at the diagnosis of first cancer was lower in pwMS (61.4y; SD 11.89) compared with controls (64.5y; 12.53; p<0.001…
multiple sclerosispwMSNTZOslo University HospitalnatalizumabADAb
…Background In January 2024, all people with multiple sclerosis (pwMS) treated with natalizumab (NTZ) at Oslo University Hospit…
COVID-19multiple sclerosispwMSCOVID-19-relatedBNT162b2ChAdOx1mRNA-1273Pfizer-BioNTechAstraZeneca/Oxford
…aired in pwMS receiving anti-CD20 or S1PR therapies, but severe COVID-19 was rare. These findings support continued vaccination programm…
Multiple SclerosisPwMSSix-Minute Walk Test
…served. Patient-reported spasticity, assessed using the MSSS88 (Multiple Sclerosis Spasticity Scale), showed a non-significant numerical decrease …
Multiple SclerosispwMSSouth Wales MS registry
…Introduction Seizures occur more commonly in people with Multiple Sclerosis (pwMS) than in the general population. We characterize a popula…
multiple sclerosispwMSADHEThigh-efficacy disease-modifying therapy
…ges and predictors of autonomic dysfunction (AD) in people with multiple sclerosis (pwMS) over a 6-year period from disease onset.Methods Among th…
Multiple SclerosispwMSMSDeutsche Multiple Sklerose GesellschaftsNfL
…dy centres throughout Germany, in collaboration with the German Multiple Sclerosis Registry set up by the German National Multiple Sclerosis Socie…
multiple sclerosisCOVID-19pwMSocrelizumabGerman MS centres
…n of B-cell depleting therapies like ocrelizumab in people with multiple sclerosis (pwMS) remains uncertain, particularly regarding delayed diseas…
multiple sclerosisMSpwMSchrononutrition
…Background Fatigue is a common symptom of multiple sclerosis (MS) and impacts quality of life, yet the role of chrononutriti…